HRPK20040293B3 - Substituted benzimidazole compounds and their use for the treatment of cancer - Google Patents

Substituted benzimidazole compounds and their use for the treatment of cancer

Info

Publication number
HRPK20040293B3
HRPK20040293B3 HR20040293A HRP20040293A HRPK20040293B3 HR PK20040293 B3 HRPK20040293 B3 HR PK20040293B3 HR 20040293 A HR20040293 A HR 20040293A HR P20040293 A HRP20040293 A HR P20040293A HR PK20040293 B3 HRPK20040293 B3 HR PK20040293B3
Authority
HR
Croatia
Prior art keywords
optionally substituted
group
aryl
alkoxy
alkyl
Prior art date
Application number
HR20040293A
Other languages
English (en)
Croatian (hr)
Inventor
Clerc Fran�ois
Hamy Fran�ois
Depaty Isabelle
Angouillant-Boniface Odile
Deprets St�phanie
Carrez Chantal
Roesner Manfred
Original Assignee
Aventis Pharma S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma S.A. filed Critical Aventis Pharma S.A.
Publication of HRP20040293A2 publication Critical patent/HRP20040293A2/hr
Publication of HRPK20040293B3 publication Critical patent/HRPK20040293B3/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/30Nitrogen atoms not forming part of a nitro radical
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/30Nitrogen atoms not forming part of a nitro radical
    • C07D235/32Benzimidazole-2-carbamic acids, unsubstituted or substituted; Esters thereof; Thio-analogues thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
HR20040293A 2001-09-26 2004-03-25 Substituted benzimidazole compounds and their use for the treatment of cancer HRPK20040293B3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01402460A EP1298125A1 (de) 2001-09-26 2001-09-26 Substituierte Benzimidazolverbindungen und ihre Verwendung zur Behandlung von Krebs
PCT/EP2002/011353 WO2003028721A2 (en) 2001-09-26 2002-09-26 Substituted benzimidazole compounds and their use for the treatment of cancer

Publications (2)

Publication Number Publication Date
HRP20040293A2 HRP20040293A2 (en) 2005-06-30
HRPK20040293B3 true HRPK20040293B3 (en) 2007-06-30

Family

ID=8182891

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20040293A HRPK20040293B3 (en) 2001-09-26 2004-03-25 Substituted benzimidazole compounds and their use for the treatment of cancer

Country Status (35)

Country Link
US (1) US7041668B2 (de)
EP (2) EP1298125A1 (de)
JP (1) JP4510450B2 (de)
KR (1) KR100891439B1 (de)
CN (1) CN100346786C (de)
AR (1) AR037096A1 (de)
AT (1) ATE386517T1 (de)
AU (1) AU2002337151B2 (de)
BR (1) BR0212856A (de)
CA (1) CA2461622C (de)
CO (1) CO5570675A2 (de)
CY (1) CY1107953T1 (de)
DE (1) DE60225159T2 (de)
DK (1) DK1432417T3 (de)
EA (1) EA006802B1 (de)
ES (1) ES2301682T3 (de)
GT (1) GT200200190A (de)
HK (1) HK1068551A1 (de)
HR (1) HRPK20040293B3 (de)
HU (1) HUP0401756A3 (de)
IL (1) IL161059A0 (de)
ME (1) MEP16808A (de)
MX (1) MXPA04002042A (de)
MY (1) MY135339A (de)
NO (1) NO327008B1 (de)
NZ (1) NZ531246A (de)
PA (1) PA8555501A1 (de)
PE (1) PE20030427A1 (de)
PL (1) PL369527A1 (de)
PT (1) PT1432417E (de)
RS (1) RS50896B (de)
SI (1) SI1432417T1 (de)
UY (1) UY27452A1 (de)
WO (1) WO2003028721A2 (de)
ZA (1) ZA200401887B (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2011250847B2 (en) * 2003-06-23 2013-06-20 Bhi Limited Partnership Methods and compositions for treating amyloid-related diseases
US20070010573A1 (en) 2003-06-23 2007-01-11 Xianqi Kong Methods and compositions for treating amyloid-related diseases
EP1678121A4 (de) * 2003-10-24 2007-07-25 Exelixis Inc Modulatoren von tao-kinase und anwendungsverfahren
DE102004010207A1 (de) 2004-03-02 2005-09-15 Aventis Pharma S.A. Neue 4-Benzimidazol-2-yl-pyridazin-3-on-Derivate
FR2868421B1 (fr) * 2004-04-01 2008-08-01 Aventis Pharma Sa Nouveaux benzothiazoles et leur utilisation comme medicaments
EP1598348A1 (de) 2004-05-18 2005-11-23 Aventis Pharma Deutschland GmbH Pyridazinonderivate als CDK2-Inhibitoren
CN101128421A (zh) 2004-12-22 2008-02-20 神经化学(国际)有限公司 治疗淀粉样相关疾病用的方法与组合物
UA92180C2 (en) * 2005-09-06 2010-10-11 Смиткляйн Бичам Корпорейшн Benzimidazole thiophene compounds as plk inhibitors
FR2891273B1 (fr) * 2005-09-27 2007-11-23 Aventis Pharma Sa NOUVEAUX DERIVES BENZIMIDAZOLES ET BENZOTHIAZOLES, LEUR PREPARATION ET LEUR UTILISATION PHARMACEUTIQUE NOTAMMENT COMME INHIBITEURS DE CMet
JP5607930B2 (ja) 2006-10-12 2014-10-15 ビーエイチアイ リミテッド パートナーシップ 3−アミノ−1−プロパンスルホン酸を送達するための方法、化合物、組成物および媒体
PA8792501A1 (es) 2007-08-09 2009-04-23 Sanofi Aventis Nuevos derivados de 6-triazolopiridacina-sulfanil benzotiazol y bencimidazol,su procedimiento de preparación,su aplicación como medicamentos,composiciones farmacéuticas y nueva utilización principalmente como inhibidores de met.
KR20100090769A (ko) * 2007-10-12 2010-08-17 아보트 러보러터리즈 2-((r)-2-메틸피롤리딘-2-일)-1h-벤즈이미다졸-4-카복스아미드 결정형 1
FR2922550B1 (fr) 2007-10-19 2009-11-27 Sanofi Aventis Nouveaux derives de 6-aryl/heteroalkyloxy benzothiazole et benzimidazole, application comme medicaments, compositions pharmaceutiques et nouvelle utilisation notamment comme inhibiteurs de cmet
FR2941951B1 (fr) 2009-02-06 2011-04-01 Sanofi Aventis Derives de 6-(6-nh-substitue-triazolopyridazine-sulfanyl) benzothiazoles et benzimidazoles : preparation, application comme medicaments et utilisation comme inhibiteurs de met.
FR2941952B1 (fr) 2009-02-06 2011-04-01 Sanofi Aventis Derives de 6-(6-substitue-triazolopyridazine-sulfanyl) 5-fluoro-benzothiazoles et 5-fluoro-benzimidazoles : preparation, application comme medicaments et utilisation comme inhibiteurs de met.
FR2941949B1 (fr) 2009-02-06 2011-04-01 Sanofi Aventis Derives de 6-(6-o-cycloalkyl ou 6-nh-cycloalkyl- triazolopyridazine-sulfanyl)benzothiazoles et benzimidazoles preparation, application comme medicaments et utilisation comme inhibiteurs de met.
FR2941950B1 (fr) 2009-02-06 2011-04-01 Sanofi Aventis Derives de 6-(6-o-substitue-triazolopyridazine-sulfanyl) benzothiazoles et benzimidazoles : preparation, application comme medicaments et utilisation comme inhibiteurs de met.
WO2011091152A1 (en) * 2010-01-22 2011-07-28 Pablo Gastaminza Inhibitors of hepatitis c virus infection
IL257486B (en) 2015-08-25 2022-07-01 Alnylam Pharmaceuticals Inc Methods and preparations for treating disorders related to the pcsk9 gene

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2441201C2 (de) * 1974-08-28 1986-08-07 Hoechst Ag, 6230 Frankfurt Anthelminthisch wirksame 2-Carbalkoxyamino-5(6)-phenyl-sulfonyloxy-benzimidazole und Verfahren zu ihrer Herstellung
DE2541752A1 (de) * 1975-09-19 1977-03-24 Hoechst Ag Anthelminthisch wirksame 2-carbalkoxyamino-5(6)-phenyl-sulfonyloxy- benzimidazole und verfahren zu ihrer herstellung
DE3247615A1 (de) * 1982-12-23 1984-07-05 Hoechst Ag, 6230 Frankfurt Substituierte phenylsulfonyloxybenzimidazolcarbaminate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
GB9900752D0 (en) * 1999-01-15 1999-03-03 Angiogene Pharm Ltd Benzimidazole vascular damaging agents
US6693125B2 (en) * 2001-01-24 2004-02-17 Combinatorx Incorporated Combinations of drugs (e.g., a benzimidazole and pentamidine) for the treatment of neoplastic disorders

Also Published As

Publication number Publication date
DE60225159T2 (de) 2009-02-19
GT200200190A (es) 2003-11-11
ATE386517T1 (de) 2008-03-15
DK1432417T3 (da) 2008-06-16
WO2003028721A2 (en) 2003-04-10
BR0212856A (pt) 2004-09-14
PL369527A1 (en) 2005-05-02
ES2301682T3 (es) 2008-07-01
AR037096A1 (es) 2004-10-20
YU21404A (sh) 2006-08-17
CY1107953T1 (el) 2013-09-04
IL161059A0 (en) 2004-08-31
EP1432417A2 (de) 2004-06-30
KR20040048904A (ko) 2004-06-10
NZ531246A (en) 2006-06-30
NO20041214L (no) 2004-06-24
US20050014811A1 (en) 2005-01-20
CA2461622C (en) 2008-12-02
EP1298125A1 (de) 2003-04-02
MEP16808A (en) 2010-06-10
DE60225159D1 (de) 2008-04-03
SI1432417T1 (sl) 2008-08-31
CA2461622A1 (en) 2003-04-10
PE20030427A1 (es) 2003-06-20
KR100891439B1 (ko) 2009-04-03
AU2002337151B2 (en) 2007-04-26
HUP0401756A3 (en) 2005-06-28
EA200400475A1 (ru) 2004-08-26
EA006802B1 (ru) 2006-04-28
HK1068551A1 (en) 2005-04-29
EP1432417B1 (de) 2008-02-20
HRP20040293A2 (en) 2005-06-30
RS50896B (sr) 2010-08-31
ZA200401887B (en) 2005-05-31
MY135339A (en) 2008-03-31
JP2005504112A (ja) 2005-02-10
CO5570675A2 (es) 2005-10-31
WO2003028721A3 (en) 2003-12-11
PT1432417E (pt) 2008-05-23
UY27452A1 (es) 2003-02-28
MXPA04002042A (es) 2004-06-07
HUP0401756A2 (hu) 2005-01-28
JP4510450B2 (ja) 2010-07-21
CN100346786C (zh) 2007-11-07
CN1558761A (zh) 2004-12-29
US7041668B2 (en) 2006-05-09
NO327008B1 (no) 2009-04-06
PA8555501A1 (es) 2003-06-30

Similar Documents

Publication Publication Date Title
HRPK20040293B3 (en) Substituted benzimidazole compounds and their use for the treatment of cancer
ATE556058T1 (de) 1-(2h)-isochinolonderivat
HRP20080113T3 (en) Substituted pyridinyl and pyrimidinyl derivatives as modulators of metabolism and the treatment of disorders related thereto
RS52978B (en) FUSIONED AMINO PIRIDIN AS HSP90 INHIBITORS
MEP61208A (en) Novel compounds having inhibitory activity against sodium-dependant transporter
NO20052074L (no) Substituerte benzoksazinoner og anvendelser derav.
HRP20070529T3 (en) Imidazole derivatives as glutmate receptor antagonists
RS54260B1 (en) AMINODIHYDROTIAZINE DERIVATIVES AS BACE INHIBITORS FOR ALZHEIMER DISEASE TREATMENT
CO5231161A1 (es) 4-aminopicolinatos y su uso como herbicidas
WO2007016392A3 (en) Benzothiazole and azabenzothiazole compounds useful as kinase inhibitors
CY1114932T1 (el) Αντιπαρασιτικοι παραγοντες
ATE447560T1 (de) Amidderivat
RS52451B (en) PHENYLPROPIONAMIDE COMPOUNDS AND THEIR USE
HRP20050775A2 (en) Quinolinone/benzoxazinone derivatives and uses thereof
DK0784054T3 (da) 1,2,3,4-tetrahydroquinoxalinderivater og deres anvendelse som glutamatreceptorantagonister
ME00981B (me) 1,2,4,5-tetrahidr0-3h-benzazepinska jedinjenja, postupak za njihovu izradu i smješe koje ih sadrže
MX344529B (es) Derivados antibioticos de 2 - oxo -oxazolidin - 3, 5 -diilo.
RS51085B (sr) Derivati dioksan-2-alkilkarbamata, postupak za njihovo dobijanje i primena istih u terapeuticima
PT1202957E (pt) Aminobenzofenonas como inibidoras de il-1beta e tnf-alpha
RS97004A (en) Benzoxazine derivatives as 5-ht6 modulators and uses thereof
ECSP066343A (es) 6-(1,1-difluoroalquil)-4-aminopicolinatos y uso como herbicidas
MY129329A (en) 6,7-DIHYDRO-5H-PYRAZOLO[1,2-a]PYRAZOL-1-ONES WHICH CONTROL INFLAMMATORY CYTOKINES
MY138466A (en) Aminoalkoxyndoles as 5-ht6-receptor ligands for the treatment of cns-disorders
HRP20030610B1 (en) Process for the preparation of mesylates of piperazine derivatives
ATE546454T1 (de) Pyrrolin-2-on-derivate gegen tumornekrosefaktor freisetzende zellen, herstellungsverfahren und anwendungen davon

Legal Events

Date Code Title Description
A1OB Publication of a patent application
AKOB Publication of a request for the grant of a patent not including a substantive examination of a patent application (a consensual patent)
PKB1 Consensual patent granted
ODRP Renewal fee for the maintenance of a patent

Payment date: 20090828

Year of fee payment: 8

PBKO Lapse due to non-payment of renewal fee for consensual patent

Effective date: 20100927